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Objective: Cardiovascular disease is the leading cause of death in patients with bipolar disorder.
The aim of this study was to evaluate the factors associated with positive coronary calcium score
(CCS) in individuals with bipolar disorder type 1.
Methods: Patients from the Bipolar Disorder Program at Hospital de Clı´nicas de Porto Alegre, Brazil,
underwent computed tomography scanning for calcium score measurement. Clinical and socio-
demographic variables were compared between patients according to their CCS status: negative
(CCS = 0) or positive (CCS4 0). Poisson regression analysis was used to examine the association of
CCS with number of psychiatric hospitalizations.
Results: Out of 41 patients evaluated, only 10 had a positive CCS. Individuals in the CCS-positive
group were older (55.264.2 vs. 43.1610.0 years; p = 0.001) and had more psychiatric hospitalizations
(4.763.0 vs. 2.662.5; p = 0.04) when compared with CCS- negative subjects. The number of previous
psychiatric hospitalizations correlated positively with CCS (p o 0.001).
Conclusion: Age and number of psychiatric hospitalizations were significantly associated with higher
CCS, which might be a potential method for diagnosis and stratification of cardiovascular disease in
bipolar patients. There is a need for increased awareness of risk assessment in this population.
Keywords: Bipolar disorder; cardiovascular diseases; diagnostic techniques; cardiovascular; coronary
disease
Introduction
Bipolar disorder (BD) is a chronic and disabling condition
associated with a pro-inflammatory systemic status1-3 and
is considered the fourth leading cause of disability-adjusted
life years (DALYs) worldwide.4 In comparison to the gen-
eral population, individuals with BD are particularly prone
to multiple metabolic conditions.5 Cardiovascular disease
is the leading cause of death in this population, with a
standardized mortality ratio of 1.5 to 2.5.6,7 In the U.S.,
individuals with BD have a five-fold increased risk of cardio-
vascular disease and manifest it 14 years earlier than
adults without mood disorders.8,9
Complex mechanisms and multiple variables are part of
the process that culminates with this increase in cardio-
vascular risk (CVR), including behavioral patterns and
genetics.10 Several established CVR factors are more
prevalent in individuals with BD, including dyslipidemia,11
hypertension,12 obesity,13,14 metabolic syndrome,15,16
and diabetes.12,17 Higher rates of cigarette smoking,18 a
sedentary lifestyle, and poor dietary habits19 are also often
observed. In addition, inflammatory and neuro-humoral
abnormalities, such as hypothalamic-pituitary-adrenal axis
and sympathetic hyperactivity, vascular inflammation, endo-
thelial dysfunction, and oxidative stress, may also contribute
to at least some of the pathophysiological mechanisms
linked to increased CVR.20
Patients with severe mental illness are often excluded
from screening and monitoring guidelines for cardiovas-
cular disease, since they are part of a specific group that
does not match the typical patient included in the large
cohort or population-based studies of CVR stratification;
they are younger, tend to have higher blood pressure, and
are more likely to be smokers.21-24 Recently, BD among
youth was one of the psychiatric conditions included in the
moderate-risk category recognized as a condition that pre-
disposes to accelerated atherosclerosis and, consequently,
early cardiovascular disease.20 For the general popula-
tion, the American Heart Association (AHA)/American
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College of Cardiology (ACC) Guideline on the Assess-
ment of Cardiovascular Risk25 recommends the use of
race- and sex-specific pooled cohort equations to predict
10-year risk of first hard atherosclerotic cardiovascular
event. If, after quantitative risk assessment, a risk-based
treatment decision is uncertain, an additional evalua-
tion, such as with coronary calcium score (CCS), may be
considered to inform treatment decision making.
CCS, a direct and noninvasive measure of coronary
atherosclerosis, is an independent and strong predictor of
cardiovascular events and all-cause mortality26-28 and
provides strong prognostic information above and beyond
clinical risk scoring methods.29 However, it is not known
whether CCS would be able to identify CVR in individuals
with BD as well as in the general population, nor whether
specific factors predict positive calcium scores in this
population.
Within this context, the aim of the present study was to
evaluate the factors associated with positive CCS in
individuals with bipolar I disorder.
Methods
Subjects
This study is a cross-sectional analysis of outpatients
with bipolar I disorder. The sample was recruited by
convenience, on the day of a medical appointment, from a
universe of 300 patients treated at the Bipolar Disorder
Program (PROTAHBI) of Hospital de Clı´nicas de Porto
Alegre, Brazil. Selected individuals agreed to participate
in the study and signed informed consent forms approved
by the institutional ethics committee.
Inclusion criteria involved having a bipolar I disorder
diagnosis per the Structured Clinical Interview for DSM-IV,
Axis I, Portuguese version (SCID-I) and being currently on
treatment. The exclusion criteria were having a diagnosis
of mental retardation or dementia, having autoimmune,
inflammatory, or infectious diseases (e.g., rheumatic con-
ditions, AIDS, diabetes), current use of medications that
might interfere with the immune response, drug abuse/
use of psychoactive substances, and pregnancy/lactation.
Instruments
Psychiatric evaluation included the SCID-I for BD diagno-
sis,30 Clinical Global Impression for Bipolar Disorder scale
(CGI-BP),31 Young Mania Rating Scale (YMRS) for manic
symptoms,32 Hamilton Depression Rating Scale (HAM-D-17)
for depressive symptoms,33 Functioning Assessment
Short Test (FAST) for functional assessment,34 and a
protocol of clinical and sociodemographic variables.
Coronary calcium scan acquisition and analysis
All computed tomography (CT) studies for coronary cal-
cium scoring were performed using a 64-row multi-
detector CT scanner (Aquilion 64 CXL; Toshiba Medical
Systems, Otawara, Japan), in a standard fashion (SCCT
guideline).35 CCS acquisitions were performed using pro-
spective electrocardiographic triggering, a tube potential
of 120 kVp and a weight-adapted tube current-time
product (250-300 mAs), covering from carina to below
the heart in end-inspiration. Images were reconstructed
with a slice thickness of 3 mm and using conventional
filtered back projection. The dose-length product of each
CCS acquisition was recorded. Reconstructed images
were reviewed and post-processed in a dedicated cardiac
workstation (Vitrea; Vital Images, Minnetonka, USA) by
an experienced and board-certified cardiac imaging spe-
cialist (FST), blinded to patient clinical information. The
Agatston method36 was used to quantify coronary calci-
fication, and results were compared to the MESA (Multi-
Ethnic Study of Atherosclerosis) database (https://www.
mesa-nhlbi.org/Calcium/input.aspx).
Data analysis
Patients were categorized into two groups according
to CCS: a CCS-negative group (CCS = 0) and a CCS-
positive group (CCS 4 0). Comparison of variables
between the two study groups relied on analysis of
variance (ANOVA) for continuous variables and the
Pearson chi-square or Fisher exact test for categorical
variables. A Poisson regression analysis was performed
to evaluate the association between CCS and count vari-
ables. Statistical analyses were performed using SPSS
version 21.0. A significance level of 0.05 was adopted for
all statistical comparisons.
Ethical aspects
This study was approved by the ethics committee of
Hospital de Clı´nicas de Porto Alegre (opinion number
13-0049). All participants provided written informed con-
sent. Throughout the process, the right to discontinue
participation in the project was assured. Participants were
informed about the characteristics of the scan, including
radiation exposure and non-use of contrast media during
CT. Results were made available in the patient’s chart
for consultation by the care team; if the CCS was 400 of
higher, the patient’s doctor was notified and the patient
was referred to the appropriate health facility.
Results
The study sample was composed of 41 patients with BD.
Most participants were female (58.5%), white (75.6%),
and married (51.2%). Demographic characteristics and
a detailed description of CVR and psychiatric factors can
be found in Table 1. Ten patients (24.4%) had a positive
CCS. Clinical variables such as hypertension, diabetes
mellitus, dyslipidemia, body mass index, abdominal cir-
cumference, and active smoking were not significan-
tly different between CCS-positive and CCS-negative
subjects.
The mean age of the entire sample was 46.1 years
(standard deviation [SD] 10.3). Patients in the CCS-
positive group were older (55.2 years; SD 4.2) than
patients in the CCS-negative group (43.1 years; SD 10.0)
(p = 0.001).
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Regarding psychiatric variables, the mean number of
previous psychiatric hospitalizations in the study popula-
tion was 3.1 (SD 2.8). The mean number of previous
psychiatric hospitalizations in CCS-positive patients was
higher compared to that of CCS-negative patients (4.7
[SD 3.0] vs. 2.6 [SD 2.5], p = 0.04). There was also a
positive association between CCS and number of previous
psychiatric hospitalizations across the entire study sample
(po 0.001) (Figure 1). The number of manic and depressive
episodes, number of suicide attempts, and history of psychotic
symptoms were not statistically different between the two
groups. The use of medications was not statistically diffe-
rent between groups, except for use of benzodiazepines
(19.3% in CCS-negative vs. 60% in CCS-positive subjects;
po 0.01). In the CCS-positive group, all subjects were in
calcium score percentile4 75, obtained using the MESA
calcium calculator (https://www.mesa-nhlbi.org/Calcium/
input.aspx) (Table 2).
Table 1 Demographic, cardiovascular risk, and psychiatric factors
Variables All patients (n=41) CCS-negative (n=31) CCS-positive (n=10) p-value
Demographic factors
Age, years 46.1610.3 43.1610.0 55.264.2 0.001
Male gender 17 (41.5) 13 (41.9) 4 (40.0) 0.91
Ethnicity
White 31 (75.6) 23 (74.1) 8 (80.0) 0.82
Nonwhite 9 (21.9) 7 (22.5) 2 (20.0)
Marital status
Single 16 (39.0) 12 (38.7) 4 (40.0) 0.44
Married 21 (51.2) 16 (51.6) 5 (50.0)
Divorced 3 (7.3) 2 (6.4) 1 (10.0)
Widowed 1 (2.4) 1 (3.2) 0 (0)
Years of education 9.963.2 10.462.9 8.363.6 0.08
Occupation
Student 1 (2.4) 1 (3.2) 0 (0)
Employed 4 (9.8) 4 (12.9) 0 (0)
Unemployed 5 (12.2) 5 (16.1) 0 (0)
Housewife 1 (2.4) 0 (0) 1 (10.0)
0.26
Social security benefits 13 (31.7) 12 (38.7) 1 (10.0)
Retired due to disability 16 (39) 8 (25.8) 8 (80.0)
Retired due to service time 1 (2.4) 1 (3.2) 0(0)
Cardiovascular risk factors
Hypertension 11 (26.8) 6 (19.3) 5 (50.0) 0.06
Diabetes mellitus
Type 1 1 (2.4) 1 (3.2) 0 (0) 0.08
Type 2 7 (17.0) 3 (9.6) 4 (40.0)
Dyslipidemia 3 (7.3) 3 (9.6) 0 (0) 0.29
Abdominal circumference 101.8614.2 101.8614.9 101.8611.0 0.99
BMI 29.566.9 30.067.1 28.266.2 0.48
Active smoking 12 (29.3) 10 (32.3) 2 (20) 0.45
Psychiatric factors
Number of previous psychiatric hospitalizations 3.162.8 2.662.5 4.763.0 0.04
Number of manic episodes 4.464.1 4.264.3 5.263.6 0.55
Number of previous depressive episodes 8.067.4 7.167.2 10.467.7 0.26
Number of previous suicide attempts 1.461.6 1.261.5 1.962.0 0.31
Presence of psychotic symptoms 26 (63.4) 21 (67.7) 5 (50.0) 0.50
FAST 32.0613.2 33.2614.3 28.469.0 0.32
Pharmacological treatment
Lithium 17 (41.4) 12 (38.7) 5 (50) 0.52
Valproic acid 22 (53.6) 17 (54.8) 5 (50) 0.79
Antipsychotics 33 (80.4) 26 (83.8) 7 (70) 0.33
Antidepressants 15 (36.5) 10 (32.2) 5 (50) 0.31
Anticonvulsants 3 (7.31) 1 (3.22) 2 (20) 0.07
Benzodiazepines 12 (29.2) 6 (19.3) 6 (60) 0.01
Data presented as n (%) or mean 6 standard deviation.
Bold font indicates statistical significance.
BMI = body mass index; CCS = coronary calcium score; FAST = Functioning Assessment Short Test.
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Discussion
Our study assessed the frequency of a positive CCS in a
sample of outpatients with BD type 1, as well as clinical
factors associated with a positive score. Patients with a
positive CCS were older and had a higher number of
previous hospitalizations for mood episodes.
Coronary atherosclerosis is a multifactorial process that
eventually leads to coronary obstruction or abrupt plaque
rupture and acute coronary events. The process usually
starts with the deposition of lipids and smooth muscle
cells in the vessel wall, along with inflammatory infiltra-
tion.37,38 Endothelial dysfunction, thickening of the vessel
wall, and continued inflammatory changes within the inti-
mal layer lead to atherosclerotic plaque formation, coro-
nary remodeling, and, eventually, encroachment into the
vessel lumen.37,38 These processes are influenced by
multiple genetic and environmental modifiers, and several
clinical risk factors for coronary artery disease (CAD)
have been established, including age, sex, cigarette smok-
ing, sedentary lifestyle, diabetes, dyslipidemia, and hyper-
tension. Inflammation is considered a cornerstone in the
atherosclerotic process.37
Regarding risk factors in Brazilian populations, in a
cross-sectional study conducted by the Brazilian Bipolar
Disorder Research Network which evaluated CVR factors
among patients with BD, high rates of smoking (27%),
physical inactivity (64.9%), alcohol use disorders (20.8%),
elevated fasting glucose (26.4%), diabetes (13.2%), hyper-
tension (38.4%), hypertriglyceridemia (25.8%), low HDL-
cholesterol (27.7%), and general (38.4%) and abdominal
obesity (59.1%) were found.39
Noninvasive evaluation of CAD has changed dramati-
cally with the advent of coronary calcium scoring. Multiple
large, population-based studies have established CCS
as the most powerful predictor of cardiovascular events,
above and beyond traditional risk factors.29 CCS has
outperformed clinical risk factors40 and other noninvasive
modalities in CVR assessment.41-43 Individuals with no
coronary calcification (CCS = 0), on the other hand, have
an excellent prognosis, with an exceedingly low incidence
of cardiovascular events for up to 15 years.44 Therefore,
CCS has the ability to reclassify individual CVR, directly
changing pharmacological and preventive measures. The
ability to detect CAD noninvasively, in rapid and repro-
ducible fashion, makes CCS an excellent measure of
in vivo atherosclerotic disease.
CCS is strongly associated with age, independently
of other CVR factors. In our study, patients with a posi-
tive CCS were older in comparison to patients with no
detectable coronary calcium, an expected phenomenon
based on large-scale studies of healthy individuals. None-
theless, all individuals with a positive CCS (100%) were
found to be in the high CVR stratum (CCS percentile 4
75),25 which would be unlikely to be related to an isolated
effect of aging. This finding illustrates a higher athero-
sclerotic risk in the sample (Table 2).
In the present study, 75.6% of patients, despite having
different traditional CVR profiles and different durations
and numbers of BD exacerbations, had a CCS of 0. The
absence of calcified plaques in the coronary arteries would
translate to an excellent prognosis regarding incident
cardiovascular events for several years. It is unknown,
however, which individuals with BD will be more prone
to experience a hard CV event even without calcified
coronary plaques as detected by CCS. In individuals with
BD, besides the increased prevalence of traditional CVR
factors, the younger age and pro-inflammatory changes
related to the disease itself may be associated with non-
calcified plaques, although this hypothesis requires con-
firmation. CCS does not detect non-calcified plaque and
Figure 1 CCS and number of previous psychiatric hospita-
lizations. CCS = coronary calcium score.
Table 2 Estimated results and percentiles according to MESA calcium calculator*
Patients Gender Age (years) Ethnicity CCS (Agatston) MESA estimate CCS-positive (%) MESA percentile
1 F 59 W 45 34 85
2 M 55 W 112 56 81
3 F 55 W 174 26 97
4 F 45 W 1 7 93
5 M 60 NW 94 46 83
6 F 56 W 703 28 99
7 M 55 W 366 56 94
8 F 58 NW 8 25 80
9 F 57 W 25 30 84
10 M 52 W 77 47 82
* https://www.mesa-nhlbi.org/Calcium/input.aspx
CCS = coronary calcium score; F = female; M = male; MESA = Multi-Ethnic Study of Atherosclerosis; NW = nonwhite; W = white.
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may not capture the true spectrum of CVR in patients with
BD. Further long-term studies with larger sample sizes
are necessary to test this hypothesis.
BD is linked to a pro-inflammatory state, which is
exacerbated in manic and depressive episodes. The
number and frequency of manic/depressive episodes
imposes a chronic and cumulative inflammatory burden
over the years.45 We observed that 24.3% of participants
in our sample study were CCS-positive. These individuals
had higher numbers of previous psychiatric hospitaliza-
tions. Our hypothesis is that patients who are more
severely ill, at advanced stages, and with more exacer-
bations of mood episodes experience a higher inflamma-
tory burden. This, together with the risk factors already
described and which probably increase with disease
progression, would lead to a potentiation of the athero-
sclerotic process and consequent increase in CVR. Con-
sidering the evidence linking accelerated atherosclerosis
in young patients with mood disorders20 and the increased
incidence of CV events in patients with BD, a possible link
between BD stage and coronary atherosclerosis can be
postulated.
One limitation of the present study is its cross-
sectional design. Due to methodological issues, we did
not have access to the lipid profile of participants, which
might have enriched our analysis of the results. Further-
more, our limited sample size may have underpowered
our ability to detect eventual associations between CCS
and other variables, as well as to control for potential
confounders.
On the other hand, our study has several strengths.
This was the first study to evaluate CCS in a sample of
patients with BD. The correlation between positive CCS
and number of psychiatric hospitalizations suggests an
association between severity of BD and alterations in
coronary calcium load, offering an important perspective
regarding cardiovascular evaluation and adequate treat-
ment in BD. Although the literature supports cardio-
vascular disease as the leading death cause in bipolar
patients, there is still a lack of studies focused on the best
method for diagnosis and stratification of CVR in this
population. As it is widely known, patients with BD do not
necessarily correspond to the general profile of the
population, and consequently may benefit from other
specific approaches. CCS may be a potential method for
diagnosis and stratification of CVR in BD patients, but
further research on the subject is required.
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